ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACAD is currently covered by 20 analysts with an average price target of $30.95. This is a potential upside of $6.28 (25.46%) from yesterday's end of day stock price of $24.67.

ACADIA Pharmaceuticals's activity chart (see below) currently has 405 price targets and 327 ratings on display. The stock rating distribution of ACAD is 70.37% BUY, 28.4% HOLD and 1.23% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.65% with an average time for these price targets to be met of 229.47 days.

Highest price target for ACAD is $39, Lowest price target is $17, average price target is $28.42.

Most recent stock forecast was given by ASHWANI VERMA from UBS on 09-Sep-2025. First documented stock forecast 06-May-2013.

Currently out of the existing stock ratings of ACAD, 57 are a BUY (70.37%), 23 are a HOLD (28.4%), 1 are a SELL (1.23%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$39

$15.39 (65.18%)

$23

6 days ago
(09-Sep-2025)

1/4 (25%)

$14.16 (57.00%)

349

Hold

$24

$0.39 (1.65%)

$23

1 months 8 days ago
(07-Aug-2025)

10/13 (76.92%)

$-0.4 (-1.64%)

157

Buy

$38

$14.39 (60.95%)

$37

1 months 8 days ago
(07-Aug-2025)

9/17 (52.94%)

$13.6 (55.74%)

238

Sell

$17

$-6.61 (-28.00%)

$12

1 months 8 days ago
(07-Aug-2025)

4/7 (57.14%)

$-7.4 (-30.33%)

186

Buy

$34

$10.39 (44.01%)

$30

1 months 22 days ago
(24-Jul-2025)

6/10 (60%)

$10.95 (47.51%)

106

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 229.47 days on average for the stock forecasts to be realized with a an average price target met ratio 66.65

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Cory Kasimov works at EVERCORE and has 8 price targets and 6 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $36.39

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Chris Howerton with lowest potential downside - -$8.61

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?